You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Adiponectin Secretion Enhancer Synthetic Organic Drug Discovery and Development

    SBC: DISCOVERYBIOMED, INC.            Topic: 200

    DESCRIPTION provided by applicant DiscoveryBioMed Inc DBM completed recently Phase I SBIR funded goals milestones specific experimental aims and efforts to screen synthetic organic small molecules on immortalized and primary differentiated human adipocyte platforms and to validate the high throughput screening HTS based Drug Discovery output with a Critical Path of bioassays dete ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  2. CC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv

    SBC: Navidea Biopharmaceuticals, Inc.            Topic: 102

    DESCRIPTION provided by applicant After an interim period of inactivity based on a select alternative commercial focus and after consultation with the FDA Neoprobe Corporation is rapidly reinitiating efforts to develop and commercialize Iodine labeled HuCC CH anti Tumor Associated Glycoprotein TAG monoclonal antibody construct as an aid to cancer surgeons who are operating on pa ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. Intraoperative assessment of non-melanoma skin cancer margins using NIRF probes.

    SBC: Akrotome Imaging, INC            Topic: 102

    DESCRIPTION provided by applicant It is predicted that approximately people will be diagnosed with nonmelanoma skin cancer this year in the United States Seventy five percent of these patients will undergo traditional excisional surgery i e non Mohs Micrographic Surgery non MMS Unlike MMS surgery traditional excision surgeries do not employ methods to determine the status of the ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. Liquid Helium Bath Free, Conduction Cooled Nb3Sn Superconducting 7 Tesla Plus Mag

    SBC: HYPER TECH RESEARCH INC            Topic: 102

    DESCRIPTION provided by applicant For tesla full body MRI bore magnet systems NbTi superconductor wire has reached its limit at K Above T if NbTi is used it requires super cooling of helium to K to achieve T bore MRI and NMR systems All these T full body MRI background magnets sold by Siemens Philips and GE have been manufactured by Aligent formerly known at Varian befor ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. A Novel Small molecule TNF-alpha inhibitor as a disease-modifying AD drug treatment.

    SBC: P2D, INC            Topic: NIA

    DESCRIPTION provided by applicant The goal of this proposal is to develop tumor necrosis factor a TNFa inhibiting compounds as neuroprotectant drugs for treating Alzheimerandapos s disease AD Current FDA approved AD interventions are symptomatic treatments with limited efficacy which do not affect AD etiology or modify the course of disease progression Thus a critical need exists for a n ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Original Phase 1 Title: Identifying Small Molecule Inhibitors of HdmX using Cell-based Screening Revised Title: Development of a Novel HdmX Inhibitor for Leukemia

    SBC: INVENIO THERAPEUTICS INC            Topic: 102

    DESCRIPTION provided by applicant Despite advances in cancer therapy the majority of cancer therapeutics in use still exhibit significant toxicity and induce DNA damage The DNA damage though toxic to non malignant cells often plays an important role in killing cancer cells through the induction of p Recently in order to develop less toxic and more targeted cancer therapies alternative ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Peripheral nerve stimulation for amputee pain

    SBC: SPR THERAPEUTICS, INC.            Topic: 108

    DESCRIPTION provided by applicant The long term goal of this research is to commercialize a neurostimulation system to treat post amputation pain Approximately million individuals in the U S are living with an amputation and about individuals undergo an amputation each year Post amputation pain has a high incidence and frequently causes further disability depression and ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Realistic Accurate Dosimulation

    SBC: Q-Track Corporation            Topic: N

    DESCRIPTION provided by applicant The proposed effort aims to enhance the realism of radiation safety training for Emergency Responders both First Responders as well as Skilled Support Personnel Our goal is to develop and evaluate realistic dosimetry simulation or andquot Dosimulationandquot tools These andquot Realistic Accurate Dosimulationandquot RAD tools will be the centerpiece fo ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for

    SBC: ATHERSYS, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant Cardiovascular disease CVD represents a significant unmet medical need with over million patients in the United States suffering from acute myocardial infarction AMI each year This epidemic of heart attacks also represents a risk factor for further cardiovascular disease with over million individuals suffering from chronic heart failure CHF and an ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  10. DBS Expert Automated Deep Brain Stimulation Programming Using Functional Mapping

    SBC: Great Lakes Neurotechnologies Inc.            Topic: 102

    DESCRIPTION provided by applicant The objective is to engineer build and clinically validate DBS Expert an expert system for optimizing postoperative programming of deep brain stimulation DBS in patients with movement disorders such as Parkinsonandapos s disease PD The clinical utility of DBS for treatment of PD is well established However great outcome disparity exists among recipien ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government